Position in MGTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$60,620,000
+$11,526,119 QoQ
Shares Held
7,000,000
+13.4% QoQ
Ownership
7.56%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rubric Capital Management LP holds $938,577,278 across 18 Biotechnology names. MGTX ranks #5 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
8,271,577 | $194,878,354 | |
| 2 | ZYME |
Zymeworks Inc.
|
7,000,000 | $175,280,000 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
5,000,000 | $138,500,000 | |
| 4 | SPRY |
ARS Pharmaceuticals, Inc.
|
8,000,000 | $64,240,000 | |
| 5 | MGTX |
MeiraGTx Holdings plc
This page
|
7,000,000 | $60,620,000 | |
| 6 | PRTA |
Prothena Corp Public Ltd Co
|
5,000,000 | $48,600,000 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
427,998 | $45,110,989 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
3,712,373 | $44,288,609 |
All Filings in MGTX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $60,620,000 | 7,000,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $49,093,881 | 6,175,331 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $30,668,691 | 3,726,451 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $24,296,460 | 3,726,451 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,043,456 | 1,776,321 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||